In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Year

    Select Year(s)

  • Session Type

    Select Session Type(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • sub-topic
  • Year
  • Session Type
  • Resource type
  • Topic
  • sub-topic
  • Year
  • Session Type
  • Resource type
  • Topic

Sponsored content

Presentations below are part of sessions sponsored by Boehringer Ingelheim

178 results for your search

Advancing the standard of care in patients with type 2 diabetes and established cardiovascular disease: how can we improve patient outcomes? .

Congress : ESC Congress 2018

  • Session : Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice
  • Speaker : N Marx (Aachen,DE), D Mcguire (Dallas,US), J Udell (Toronto,CA), S Verma (Toronto,CA), N Sattar (Glasgow,GB)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance

Applying breakthroughs in AF ablation to your clinical practice.

Congress : EHRA 2018

  • Session : Uninterrupted dabigatran: exploring the impact on AF ablation
  • Speaker : D Gupta (Liverpool,GB)
  • Sponsored by Boehringer Ingelheim

Applying evidence in practice: appropriate use of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in the cardiology clinic.

Congress : ESC Congress 2018

  • Session : Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice
  • Speaker : J Udell (Toronto,CA), N Sattar (Glasgow,GB)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance

Bringing order to complexity: antithrombotic regimens for atrial fibrillation patients who underwent PCI.

Congress : ESC Congress 2018

  • Session : Bringing order to complexity: antithrombotic regimens for atrial fibrillation patients who underwent percutaneous coronary intervention
  • Speaker : C P Cannon (Boston,US), J M Ten Berg (Nieuwegein,NL)
  • Sponsored by Boehringer Ingelheim

Close - Reducing premature cardiovascular mortality in patients with type 2 diabetes: best practice in cardiology

Congress : ESC Congress 2018

  • Session : Reducing premature cardiovascular mortality in patients with type 2 diabetes: best practice in cardiology
  • Speaker : S D Anker (Berlin,DE)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance

Comprehensive patient care: from OAC choice to post-PCI (and beyond).

Congress : ESC Congress 2018

  • Session : Translating trials to clinical practice: is dual therapy the new standard of care for atrial fibrillation patients post-PCI?
  • Speaker : G Nickenig (Bonn,DE)
  • Sponsored by Boehringer Ingelheim

Contemporary pharmaco-invasive strategies in the real world.

Congress : ESC Congress 2018

  • Session : Spotlights on optimisation of guideline-supported reperfusion strategies for STEMI
  • Speaker : N Danchin (Montreuil,FR)
  • Sponsored by Boehringer Ingelheim

Discussion and close: anticoagulation in atrial fibrillation and beyond.

Congress : ESC Congress 2018

  • Session : Dabigatran use in diverse cardiology settings
  • Speaker : J Halperin (New York,US), G Y H Lip (Birmingham,GB)
  • Sponsored by Boehringer Ingelheim

Does OAC reversal matter to your cardiac patients?

Congress : ESC Congress 2018

  • Session : Dabigatran use in diverse cardiology settings
  • Speaker : C Pollack (Philadelphia,US)
  • Sponsored by Boehringer Ingelheim

Dual vs triple therapy in atrial fibrillation post-PCI: how has the story evolved?

Congress : ESC Congress 2018

  • Session : Translating trials to clinical practice: is dual therapy the new standard of care for atrial fibrillation patients post-PCI?
  • Speaker : C P Cannon (Boston,US)
  • Sponsored by Boehringer Ingelheim

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are